Actively Recruiting

Age: 18Years +
All Genders
NCT05076500

Investigating the Tumour Immune Response of Radiotherapy

Led by University of Manchester · Updated on 2025-06-11

120

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

Sponsors

U

University of Manchester

Lead Sponsor

T

The Christie NHS Foundation Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to investigate immune changes which occur before and following standard radiotherapy in a range of tumour types. We will collect tissue and blood samples before and after radiation treatment from participants across six cancer types: cervical, rectal, Head and Neck cancer, nodal non-Hodgkin lymphoma, cutaneous lymphoma and cutaneous squamous cell carcinoma/ basal cell carcinoma.

CONDITIONS

Official Title

Investigating the Tumour Immune Response of Radiotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed cancer, Stage I-IV, in one of the following: Cervical, rectal, nodal Non-Hodgkin lymphoma, cutaneous lymphoma, Head & neck cancer
  • Diagnostic or pre-treatment biopsy confirmed suitable for translational research
  • Performance status ECOG 0-2 (ECOG 3 allowed for arm F unrelated to cancer)
  • Age 18 years or older, no upper age limit
  • Participant considered suitable for radiotherapy
  • Written informed consent given according to GCP and national regulations
  • Pre-treatment biopsy from gross tumour volume within planned radiation field, formalin fixed >12h and <72h, tumour tissue confirmed by H&E staining, and contains approximately 100 tumour cells
Not Eligible

You will not qualify if you...

  • Unsuitable for biopsy during or after radiotherapy as judged by treating oncologist
  • Received chemotherapy within 28 days before starting radiotherapy
  • Known history or current infection with hepatitis B, hepatitis C, or HIV (negative test required before inclusion)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Christie NHS Foundation Trust

Manchester, United Kingdom, M20 4BX

Actively Recruiting

Loading map...

Research Team

L

Lois Gardner

CONTACT

E

Eleanor Cheadle

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here